Pseudotumor cerebri (PTC) is a neurological condition caused by cerebrospinal fluid (CSF) build-up within the skull. PTC has been linked with the use of levonorgestrel-releasing birth control devices, including the Mirena IUD. Plaintiffs allege that Bayer knew about Mirena’s potential pseudotumor cerebri risks, yet failed to properly warn consumers or healthcare providers.
Time is limited! Fill out the form on this page to see if you qualify.
An advocate or attorney will contact you within minutes for your free consultation.
No fees unless you are awarded compensation!
The Mirena intrauterine device (IUD) is a popular, FDA-approved long-term contraceptive device that works by releasing a type of progestin known as levonorgestrel. In addition to using the Mirena IUD to prevent pregnancy for up to five years, it’s also prescribed to treat heavy menstrual bleeding.
Women diagnosed with pseudotumor cerebri after Mirena IUD implantation began suing the device’s manufacturer, Bayer HealthCare Pharmaceuticals, in 2014. These plaintiffs allege that Bayer knew about Mirena’s potential pseudotumor cerebri risks, yet failed to properly warn consumers or healthcare providers. In April 2017, 113 federal PTC lawsuit claims were consolidated under a multi-district litigation.
More and more women diagnosed with PTC after Mirena IUD implantation are now filing claims against Bayer. If you or a loved one experienced symptoms of pseudotumor cerebri, you may be entitled to a cash settlement. Get started with your free claim review now to see if you may qualify for financial compensation.